Pansuriya, Vraj B. and Kapadiya, Khushal M. and Rathod, Suryajitsinji L. and Prajapati, Usha B. and Vavaiya, Bhavin M. and Padariya, Jasmin B. and Vaidya, Foram U. and Pathak, Chandramani and Parekh, Hitesh M. (2021) Anti-Cancer Activity of Gabapentin and Chiral Amino Acids-Based Hybrid-Peptides against MCF-7 Breast Cancer Cell-Line. Journal of Pharmaceutical Research International, 33 (46A). pp. 431-446. ISSN 2456-9119
3694-Article Text-5457-1-10-20221006.pdf - Published Version
Download (581kB)
Abstract
Aims: Herein, we report the cytotoxicity of gabapentin-based peptides (11a-11j) using L-alanine and L-phenyl alanine chiral amino acids for peptide bond formation in ten efficient and straightforward steps. The in vitro MTT assays of derived molecules on the MCF-7 cell line (a human breast adenocarcinoma cell line) exhibited enhanced antitumor activity compared to the control (100% cell proliferation).
Methods: The ten steps synthetic methods were adapted for the synthesis of the Gabapentin-based peptide derivatives through BOC- deBOC methods and using EDC-HCl, DMAP and commercially available solvents. All the synthesized peptides were unambiguously characterized with the help of spectroscopic (IR, 1H NMR, 13C-NMR, mass spectra, and elemental) data analysis.
Results: The Compounds 11a, 11b, 11h,11i, and 11j showed a remarkable antiproliferative (cell death) activity, with % cell proliferation values ranging from 25-38 %.
Conclusion: The study showed that the compounds with some specific functionalities like, benzylic and trifluoromethyl functionality enhanced the potency with comparable %cell proliferation and cell death. Based on the findings in this work and their easily accessible molecular structures, compounds 11a and 11j are worthy of further biological investigations.
Item Type: | Article |
---|---|
Subjects: | Impact Archive > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 26 Apr 2023 04:29 |
Last Modified: | 27 Feb 2024 04:04 |
URI: | http://research.sdpublishers.net/id/eprint/1845 |